Targeting CD19 for the treatment of autoimmune with a novel T cell engager
A. Q. Yuan, L. Zhao, L. Bai, Y. Wang, I. Yang, R. Q. Yuan, Q. Meng, X. Dai
This study develops YK012, a T cell engager targeting CD19, showing potential for treating autoimmune diseases with improved efficacy and reduced side effects compared to existing therapies.
bioRxiv · Feb 17, 2024Immunology